MPP⁺ Neuronal Cell Death Assay Service
Advance your Parkinson's disease (PD) research with our efficient and accurate MPP+-induced neuronal cell death detection solutions. We empower researchers to gain deeper insights into the disease's pathogenesis and accelerate the screening of potential therapeutic drugs. For further information regarding the products and services provided, project-specific consultation, and pricing, please submit an inquiry here.
Introduction
Distributed under Open Access license CC BY-SA 4.0, from Wiki,
without modification.
MPP+ (1-methyl-4-phenylpyridinium ion) is a metabolite of MPTP (1-methyl-4-phenyl-2,3,6,7-tetrahydropyridine) and an important neurotoxin in PD research. It mainly enters dopaminergic neurons through the dopamine transporter (DAT) and accumulates inside the cells, inhibiting the mitochondrial electron transport chain complex I, leading to ATP depletion, increased production of reactive oxygen species (ROS), and cell death. In addition, MPP+ also induces the death of dopaminergic neurons through the combined action of oxidative stress and specific neurotoxins.
Our MPP+ Neuronal Cell Death Assays
- Advanced Modeling System
Human iPSC-derived Neurons: Utilizing human induced pluripotent stem cell (iPSC)-derived neurons to create more physiologically relevant models and study the impact of genetic variability on MPP+ toxicity.
Co-culture Systems: Incorporating multiple cell types, such as astrocytes and microglia, to recreate the complex cellular environment of the brain and study cell-cell interactions in neurotoxicity.
Controllable Conditions: Our MPP+-induced neuronal cell death platform offers unparalleled control over experimental conditions. By manipulating key environmental factors, we can distinguish between apoptotic and non-apoptotic cell death modes, providing critical insights for developing targeted therapies.
Fig.1 Representative images of primary mouse cortical tri-culture, NeuN (neuronal marker), GFAP (astrocyte marker) and Iba1 (microglia marker). Images acquired using Zeiss LSM 980.
- Comprehensive Detection Indicators
Cell Viability and Morphology: Quantify cell survival rates and apoptotic features using MTT assays and Hoechst/PI double staining, precisely reflecting neuronal damage across MPP⁺ concentration gradients.
Mitochondrial Dysfunction: Assess mitochondrial health by measuring ROS levels, cytochrome c release, and changes in mitochondrial membrane potential, key indicators of mitochondrial dysfunction.
Programmed Cell Death Pathways: Investigate the activation of key cell death pathways, including Caspase-3 activation (apoptosis), AIF nuclear translocation (caspase-independent apoptosis), and LC3-II accumulation (autophagy).
Calcium Signaling Dysregulation: Monitor MPP+-induced Ca2+ overload and its association with lysosomal dysfunction using fluorescent probes, revealing the interplay between calcium signaling and neurodegeneration.
Fig.2 Fluorescence detection of intracellular reactive oxygen species.1
- High Throughput Detection Platform
Our MPP+-induced neuronal cell death platform is optimized for high-throughput screening, enabling researchers to efficiently evaluate the effects of multiple compounds on neurodegeneration. We support both 96-well and 384-well plate formats, allowing for rapid and cost-effective screening of large compound libraries.
Our MPP+ neuronal cell death assay service is your trusted partner in the fight against neurodegeneration. We provide comprehensive support, cutting-edge technology, and expert analysis to accelerate your research and drive the development of innovative therapies. Please contact us and let us work together.
Reference
- Lu, Xi-Lin, et al. "Paeonolum protects against MPP+-induced neurotoxicity in zebrafish and PC12 cells." BMC Complementary and Alternative Medicine 15 (2015): 1-10. Distributed under Open Access license CC BY 4.0, without modification.
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- Human Retinal Epithelial Cell ARPE-19 (Cat#: NCL2110P069)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- Human Brain Microvascular Endothelial Cells (Cat#: NCL-2103-P133)
- Mouse Glioma Cell Line GL261-GFP (Cat#: NCL-2108P04)
- iNeu™ Human Motor Neurons (Cat#: NCL-2103-P71)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- Mouse Glioma Cell Line GL261 (Cat#: NCL-2108P28)
- Green Fluorescent Alpha-synuclein Cell Line (Cat#: NCL2110P209)
- Green Fluorescent Tau cell Line (Cat#: NCL2110P219)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
